Zai Lab Quarterly Balance Sheet
NASDAQ: ZLABHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Zai Lab financial position
As of Jun 30, 2026, Zai Lab reported total assets of $1.07 billion, down 7.7% from a year earlier against total liabilities of $467.8 million. Shareholders' equity stood at $607.0 million, or 56.5% of assets. The company held $607.5 million in cash and equivalents against $238.1 million of debt, a net cash position of $369.4 million.
The current ratio (current assets divided by current liabilities) was 2.13, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.39.
Summary generated from market data by MetaCap's automated system. Methodology
Zai Lab balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 607.52M | 651.32M | 679.57M | 717.15M | 732.16M | 757.26M | 449.67M | 616.09M | 630.05M | 650.78M | 790.15M | 788.81M |
| Short-Term Investments | 10.00M | 10.00M | 10.00M | 0 | 0 | 0 | 330.00M | 0 | 0 | 0 | 16.30M | 31.60M |
| Receivables | 69.59M | 54.07M | 106.12M | 85.38M | 88.50M | 76.56M | 85.18M | 49.97M | 69.64M | 60.42M | 59.20M | 41.60M |
| Inventory | 90.89M | 85.96M | 74.75M | 67.14M | 61.70M | 53.05M | 39.88M | 39.55M | 41.85M | 37.85M | 44.83M | 44.23M |
| Total Current Assets | 914.04M | 944.73M | 1.02B | 1.03B | 1.03B | 1.04B | 1.05B | 860.55M | 869.92M | 888.64M | 939.61M | 959.73M |
| Property, Plant & Equipment | 46.43M | 47.07M | 47.39M | 48.87M | 50.16M | 49.65M | 47.96M | 50.77M | 50.61M | 52.39M | 53.73M | 55.28M |
| Intangible Assets | 85.77M | 75.76M | 76.14M | 55.28M | 56.52M | 56.20M | 56.03M | 51.67M | 44.06M | 12.40M | 13.39M | 1.57M |
| Long-Term Investments | — | — | — | — | — | — | 3.12M | 3.15M | 4.07M | 14.11M | 9.22M | 4.47M |
| Total Assets | 1.07B | 1.10B | 1.17B | 1.16B | 1.16B | 1.17B | 1.19B | 985.35M | 987.37M | 988.44M | 1.04B | 1.04B |
| Accounts Payable | 136.69M | 126.17M | 141.61M | 99.71M | 107.36M | 103.02M | 100.91M | 120.65M | 127.34M | 88.12M | 112.99M | 55.02M |
| Short-Term Debt | 238.10M | 213.82M | 204.53M | 203.03M | 174.51M | 173.41M | 131.71M | 112.99M | 70.30M | 48.27M | 0 | — |
| Total Current Liabilities | 428.58M | 392.98M | 416.17M | 359.77M | 331.50M | 319.81M | 299.38M | 286.31M | 251.72M | 192.11M | 203.07M | 124.90M |
| Total Liabilities | 467.76M | 433.76M | 456.88M | 399.00M | 372.37M | 362.58M | 344.86M | 317.68M | 283.19M | 226.27M | 240.18M | 162.72M |
| Shareholders' Equity | 607.04M | 661.98M | 715.50M | 759.95M | 791.74M | 810.75M | 840.90M | 667.67M | 704.18M | 762.17M | 796.12M | 880.98M |
| Retained Earnings | -2.73B | -2.68B | -2.63B | -2.58B | -2.54B | -2.50B | -2.45B | -2.37B | -2.33B | -2.25B | -2.20B | -2.10B |
| Total Debt | 238.10M | 213.82M | 204.53M | 203.03M | 174.51M | 173.41M | 131.71M | 112.99M | 70.30M | 48.27M | 0 | — |
| Net Cash (Debt) | 379.42M | 447.50M | 485.04M | 514.13M | 557.65M | 583.86M | 647.96M | 503.09M | 559.75M | 602.51M | 806.45M | 820.41M |
| Shares Outstanding | 1.12B | 1.11B | 1.11B | 1.11B | 1.10B | 1.08B | 1.08B | 984.36M | 981.40M | 973.29M | 972.24M | 969.04M |
This table shows 12 quarterly periods of Zai Lab's balance sheet, from Q2 2026 back to Q3 2023, across 18 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow ZLAB's reporting calendar. What is a balance sheet?